Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5100196 | 0.78 | BCHE (0.33) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL2266459 | 0.74 | — | — | |
| Iodide SCHEMBL7629995 | 0.74 | — | — | |
| SCHEMBL5096451 | 0.71 | AGER (0.41) | — | |
| SCHEMBL3113482 | 0.67 | ALDH1A1 (0.32) | — | |
| SCHEMBL3040485 | 0.65 | BCHE (0.31) | BCHEACHE | |
| SCHEMBL1231917 | 0.65 | — | — | |
| SCHEMBL3235514 | 0.65 | TSHR (0.47) | — | |
| Lithium Ion SCHEMBL1034873 | 0.65 | — | — | |
| SCHEMBL587115 | 0.65 | TSHR (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439395-B2 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | claimed |
| EP-1711458-B1 | METHOD FOR PRODUCING GUANIDINIUM SALTS | MERCK PATENT GMBH (DE) | 2013-05-29 | — | — | EP | disclosed |
| US-7439395-B2 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20070135645-A1 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
| EP-1711458-A1 | METHOD FOR PRODUCING GUANIDINIUM SALTS | MERCK PATENT GmbH (DE) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005075413-A1 | METHOD FOR PRODUCING GUANIDINIUM SALTS | MERCK PATENT GMBH (DE) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135645-A1 | Process for the preparation of guanidinium salts | GMPS, AGPS, PFAS | ACHE 1428/4885BCHE 1990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.